Accenture (ACN) director reports 7 RSUs in Form 4 filing
Accenture plc director Paula A. Price reported a small equity grant in the form of restricted share units.
Rhea-AI Filing Summary
Accenture plc director Paula A. Price reported a small equity grant in the form of restricted share units. On 11/14/2025 she received 7 Class A ordinary shares through a grant of restricted share units priced at $0 per share, reflecting an anti-dilution adjustment tied to Accenture plc's payment of a cash dividend under previously granted RSU awards. Following this transaction, she beneficially owns 7,368 Class A ordinary shares on a direct basis.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A ordinary shares | 7 | $0.00 | $0.00 |
Footnotes (1)
- F1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.
FAQ
What did Accenture (ACN) disclose in this Form 4 filing?
The filing shows that director Paula A. Price received a grant of 7 Class A ordinary shares on 11/14/2025 through restricted share units, and now directly owns 7,368 shares.
What type of security was involved in this Accenture (ACN) Form 4?
The transaction involved Class A ordinary shares of Accenture plc, acquired through a restricted share unit (RSU) grant.
Does this Accenture (ACN) Form 4 indicate a Rule 10b5-1 trading plan?
The form includes a checkbox for transactions made under a Rule 10b5-1(c) trading plan, but the excerpt only shows that such an option exists and does not state that it was selected for this RSU grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.